Open radical cystectomy
ProcedureStandard of care removal of urinary bladder.
NCT Number: NCT01157676
This is a multi-institutional, randomized trial evaluating oncologic, perioperative, and functional outcomes following two standard care procedures for radical cystectomy. The participants will have one of the standard care procedures as part of their care. The two procedures that will be followed are open radical cystectomy and robotic assisted radical cystectomy (RARC). Open cystectomy is considered to be the more traditional approach. While newer, RARC is considered to be equivalent to open surgery when it is performed by a trained robotics surgeon. The reported complication rates of RARC appear comparable to open surgery. This means there is no significant difference in the risk between the two standard procedures. However, despite these potential advantages, true comparison between the open and robotic technique with regards to long term cancer related and functional outcomes has not been accomplished because previous studies did not compare patients of equal health status. The researchers hope to learn whether or not patients undergoing RARC recover more quickly than or at the same rate as patients undergoing an open radical cystectomy while having non inferior cancer related outcomes. This study is funded by the National Institutes of Health (NIH).
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Mayo Clinic Arizona, Phoenix, Arizona, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Standard of care removal of urinary bladder.
Standard of care removal of urinary bladder using DaVinci robot.
DaVinci robotic surgical system.
Time frame: 24 months
Progression will be determined by the treating physician using the Response Evaluation Criteria in Solid Tumors (RECIST) Version 1.1 criteria based on radiographic or pathological evidence of disease progression or death from disease.
Time frame: At time of cystectomy, approximately 1 hour.
Evaluated are the number of participants with positive surgical, bladder, and urethral margins. Positive margin is defined as presence of tumor cells at the edge of the dissected tissue.
Time frame: At time of cystectomy, approximately 1 hour
Evaluated are the number of participants requiring extended or standard lymph node dissection
Time frame: at baseline, 3 month, and 6 months
Functional Assessment of Cancer Therapy- Vanderbilt Cystectomy Index (FACT-VCI) scores range is 0-168 which is sum of physical, emotional, wellbeing, and FACTS Bl Cys. higher scores=better QOL.
Time frame: 90 days post operative
Post surgical complications will be evaluated using the Clavien grading system with scores ranging from 0-5 with the higher number indicating increased post-surgical complications.
Time frame: At time of cystectomy, approximately 1 hour
Perioperative measures such as EBL will be evaluated by measuring the amount of participant blood loss in ml.
Time frame: At time of cystectomy, approximately 1 hour
Number of participants requiring peri, intra, and post operative blood transfusion.
Time frame: Day 10 post surgery
Number of days of post operative length of hospital stay will be evaluated
Time frame: At time of cystectomy, approximately 1 hour
Length of minutes of cystectomy procedure
Time frame: baseline, 6 weeks, 3 months, 6 months, 12 months, 24 months, 36 months
Serum Hemoglobin (Hb) and Albumin will be reported in grams per deciliters (g/dL)
Time frame: baseline, 1 month , 3 months, 6 months
Participant reported ADL questionnaire is a 7 item questionnaire with scores ranging from 7-21 with a lower score indicating increased independence.
Time frame: 3 years
Progression will be determined by the treating physician using the RECIST Version 1.1 criteria based on radiographic or pathological evidence of disease progression or death from disease.
Time frame: baseline, 3 month, and 6 month
The SF-8 consists of two component summary scores; physical (PCS) and mental component summary (MCS). They are scored by weighting each score to a norm-based scoring model. The total scores will be reported as a percentile with higher score indicating better quality of health.
Time frame: At time of cystectomy, approximately 1 hour
Total number of participants requiring Intra-operative fluid requirement. (blood+plasma+platelets) Note: In robotic group 1 participant received both plasma and platelets and 1 other received platelets in addition to blood transfusion. In the open group 5 participants received plasma in addition to blood transfusion.
Time frame: At time of cystectomy, approximately 1 hour
Total postoperative analgesic requirements in milli grams
Time frame: baseline, 6 weeks, 3 months, 6 months, 12 months, 24 months, 36 months
Serum creatinine will be reported in milligrams per deciliters (mg/dL).
Time frame: baseline, 1 month, 3 months, 6 months
Participant reported IADL questionnaire is an 8 item questionnaire with scores ranging from 8-32 with a lower score indicating increased independence.
Time frame: baseline, 1 month, 3 months, 6 months
The hand grip strength test is measured in kilograms of pressure using a handheld dynamometer.
Time frame: baseline, 1 month, 3 months, 6 months
The TUG test is measured in seconds. Patients will be timed as they rise from a standard chair, walk 3 meters, turn, walk back, and sit again.
Time frame: baseline, 3 months, 6 months
FACT-VCI consists of eight domains: Five subscale scores (physical wellbeing, social wellbeing, emotional wellbeing, functional wellbeing, and FACT for patients with Bladder Cancer following Cystectomy [FACT-BL-Cys]) and three derived scores (trial outcome index), FACT-General form (FACT-G), and FACT-BL-Cys Total.The ranges of scores for each domain are as follows: 0-28 for physical, social, and functional wellbeing; 0-24 for emotional wellbeing; 0-60 for FACT-BL-Cys; 0-116 for FACT-VCI Trial Outcome Index (sum of physical wellbeing, functional wellbeing, and FACT-BL-Cys scores); 0-108 for FACT-G (sum of physical, social, emotional, and functional wellbeing scores); and 0-168 for FACT-BL-Cys Total (sum of physical, social, emotional, and functional wellbeing scores, and FACT-BL-Cys).The higher score indicates increased wellbeing.
Time frame: Day 7
Fixed and variable costs associated with the procedure.
University of Miami
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07655284
Bladder Cancer Requiring Cystectomy, Female Urogenital Diseases
Boston, Massachusetts, United States
View Trial DetailsNCT07140588
Bladder Cancer Requiring Cystectomy, Erectile Dysfunction Following Radical Prostatectomy
View Trial DetailsNCT07067749
Bladder (Urothelial, Transitional Cell) Cancer, Bladder Cancer Requiring Cystectomy
Rome, RM, Italy
View Trial DetailsNCT06595446
Bladder Cancer Requiring Cystectomy, Female Urogenital Diseases
London, Ontario, Canada
View Trial Details